Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Amgen
Amgen
C4 Therapeutics, Inc.
Faculdade de Ciências Médicas de Minas Gerais
OncoNano Medicine, Inc.
University of Texas Southwestern Medical Center
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Rabin Medical Center
Beijing Chao Yang Hospital